Therapeutic Advances in Respiratory Disease

Scope & Guideline

Empowering Progress in Respiratory Disease Management

Introduction

Welcome to the Therapeutic Advances in Respiratory Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Therapeutic Advances in Respiratory Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1753-4658
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationTHER ADV RESPIR DIS / Ther. Adv. Respir. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Therapeutic Advances in Respiratory Disease' primarily focuses on advancing knowledge and therapeutic strategies related to respiratory diseases. It encompasses a broad range of studies aimed at improving patient outcomes through innovative research and clinical practice. The journal emphasizes the integration of clinical findings, therapeutic advancements, and patient-reported outcomes in the field of respiratory health.
  1. Clinical Research in Respiratory Diseases:
    The journal publishes original research on various respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and infections, emphasizing clinical trials and observational studies.
  2. Innovative Therapeutic Approaches:
    It highlights studies on novel therapeutic interventions, including pharmacological treatments, biologics, and advanced medical technologies such as robotic-assisted bronchoscopy and endobronchial ultrasound.
  3. Diagnostic Advances:
    Research focusing on novel diagnostic methods and biomarkers for respiratory diseases is a key area, including studies on imaging techniques, molecular diagnostics, and the validation of clinical assessment tools.
  4. Patient-Centered Outcomes:
    The journal places a strong emphasis on patient-reported outcomes, quality of life assessments, and the psychosocial aspects of living with respiratory diseases, aiming to incorporate patient perspectives into clinical practice.
  5. Epidemiology and Public Health:
    It includes epidemiological studies that analyze the prevalence, risk factors, and burden of respiratory diseases in various populations, providing insights into public health implications.
Recent publications in 'Therapeutic Advances in Respiratory Disease' reflect emerging trends and themes that are gaining traction. These areas indicate the journal's responsiveness to current challenges and advancements in respiratory medicine.
  1. Personalized Medicine and Biomarkers:
    There is a growing focus on personalized treatment strategies and the identification of biomarkers that guide therapy, particularly in complex diseases like asthma and COPD, highlighting the importance of individualized patient care.
  2. Impact of COVID-19 on Respiratory Health:
    Research examining the long-term effects of COVID-19 on respiratory health, including post-acute sequelae and rehabilitation strategies, has seen a significant rise, reflecting an urgent need for addressing the pandemic's implications.
  3. Interventional Pulmonology Techniques:
    Emerging interest in advanced interventional techniques such as endobronchial ultrasound and robotic bronchoscopy is evident, showcasing the journal's commitment to reporting on innovative procedures that enhance diagnostic and therapeutic capabilities.
  4. Telemedicine and Digital Health Solutions:
    The incorporation of telemedicine and digital health solutions into respiratory disease management is trending, with studies focusing on their effectiveness in improving access to care and patient outcomes during and after the COVID-19 pandemic.
  5. Multidisciplinary Approaches to Treatment:
    There is an increasing emphasis on multidisciplinary care models that integrate various specialties to address the complex needs of patients with respiratory diseases, reflecting a holistic approach to treatment.

Declining or Waning

As the field evolves, certain themes within 'Therapeutic Advances in Respiratory Disease' appear to be losing prominence. This decline may reflect shifting research priorities or advancements in understanding that have made some previously emphasized topics less critical or relevant.
  1. Traditional Therapeutic Approaches:
    There is a noticeable decrease in research focusing solely on traditional pharmacological therapies, such as older inhalers and medications, as more emphasis is placed on novel therapies and personalized medicine.
  2. Basic Science Research:
    The journal has seen a reduction in the publication of purely basic science studies that do not directly translate to clinical application, indicating a shift towards more clinically relevant research.
  3. Single-Disease Focus Studies:
    Research dedicated to single diseases without interdisciplinary approaches is waning, as the journal increasingly emphasizes studies that consider comorbid conditions and multifactorial influences on respiratory health.

Similar Journals

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Exploring the Frontiers of Cardiology and Pulmonology
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Respiratory Investigation

Exploring the depths of pulmonary innovations.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

Pulmonology

Exploring the frontiers of respiratory health and innovation.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Annals of the American Thoracic Society

Empowering professionals with the latest in thoracic science.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Annals of Thoracic Medicine

Fostering collaboration in the pursuit of thoracic excellence.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Pulmonary Therapy

Exploring breakthroughs in respiratory medicine for a healthier tomorrow.
Publisher: SPRINGERNATUREISSN: 2364-1754Frequency: 2 issues/year

Pulmonary Therapy is a leading open-access journal published by SpringerNature, dedicated to advancing the field of pulmonary and respiratory medicine as well as respiratory care. Established in 2015 and situated in the United Kingdom, the journal has rapidly gained recognition, evidenced by its impressive Q2 quartile rankings in both the Pulmonary and Respiratory Medicine and Respiratory Care categories as of 2023. With a focus on innovative research, the journal provides a platform for the dissemination of high-quality studies that address critical issues in respiratory health. Leveraging the open access model, it ensures wide dissemination and accessibility of knowledge amongst researchers, healthcare professionals, and students, thereby fostering collaborative advancements in treatment approaches and preventive care strategies. As the field continues to evolve, Pulmonary Therapy remains committed to publishing impactful scientific contributions that shape the future of respiratory medicine.

Egyptian Journal of Bronchology

Connecting researchers and practitioners in bronchial health.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Enhancing clinical outcomes through impactful research.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Zeitschrift fur Pneumologie

Fostering Collaboration for Lung Health Advancement
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

RESPIRATORY MEDICINE

Advancing the Frontiers of Pulmonary Health
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.